Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Locally Advanced Prostate Cancer and Biomarker Research

NCT04894188 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT04894188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04894188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Locally Advanced Prostate Cancer and Biomarker Research
Lead sponsor
National Taiwan University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
January 27, 2022
Completion date
July 1, 2041
Enrollment
38 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer